100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Previously searched by you
Previously searched by you
logo
TEST BANK FOR CLAYTON’S BASIC PHARMACOLOGY FOR NURSES 19TH EDITION BY MICHELLE J. WILLIHNGANZ, SAMUEL L. GUREVITZ, BRUCE CLAYTON CHAPTER 1-48 $16.49
Add to cart
Quickly navigate to
Preview
  2.  
  3. CLAYTON’S BASIC PHARMACOLOGY FOR NURSES 19TH ED
  4.  
  5. CLAYTON’S BASIC PHARMACOLOGY FOR NURSES 19TH ED

Exam (elaborations)

TEST BANK FOR CLAYTON’S BASIC PHARMACOLOGY FOR NURSES 19TH EDITION BY MICHELLE J. WILLIHNGANZ, SAMUEL L. GUREVITZ, BRUCE CLAYTON CHAPTER 1-48
 0 purchase
  • Course
  • CLAYTON’S BASIC PHARMACOLOGY FOR NURSES 19TH ED
  • Institution
  • CLAYTON’S BASIC PHARMACOLOGY FOR NURSES 19TH ED

TEST BANK FOR CLAYTON’S BASIC PHARMACOLOGY FOR NURSES 19TH EDITION BY MICHELLE J. WILLIHNGANZ, SAMUEL L. GUREVITZ, BRUCE CLAYTON CHAPTER 1-48

Preview 4 out of 407  pages

Document information

  • September 1, 2024
  • 407
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers

Subjects

  • isbn 978 0323796309
  • claytons basic pharmacology for nurses 19th ed
  • test bank for claytons basic pharmacology for nur
  • claytons basic pharmacology for nurses
  • test bank

Connected book

book image

Book Title:

Author(s):

  • Edition:
  • ISBN:
  • Edition:

More summaries for

All for this textbook (95)

Written for

  • CLAYTON’S BASIC PHARMACOLOGY FOR NURSES 19TH ED
  • CLAYTON’S BASIC PHARMACOLOGY FOR NURSES 19TH ED

Seller

avatar-seller
Ascorers

Reviews received

Content preview

TEST BANK FOR CLAYTON’S BASIC
PHARMACOLOGY FOR NURSES 19TH EDITION BY
MICHELLE J. WILLIHNGANZ, SAMUEL L. GUREVITZ,
BRUCE CLAYTON CHAPTER 1-48




written by
V




ASCORERS

, 1


Chapter 01: Drug Definitions, Standards, and Information Sources
V V V V V V V

Willihnganz: Clayton’s Basic Pharmacology for Nurses, 19th Edition
V V VV VV VV VV VV VV




MULTIPLE VCHOICE

1. Which Vname Videntifies Va Vdrug Vlisted VbyVthe VUS VFood
Vand VDrug VAdministration V(FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: V C
The Vofficial Vname Vis Vthe Vname Vunder Vwhich Va Vdrug Vis
V listed V by Vthe V FDA. VThe V brand V name, Vor Vtrademark, Vis Vthe

Vname Vgiven Vto Va Vdrug V by V its V manufacturer. VThe

Vnonproprietary, Vor Vgeneric, V name V is Vprovided V by Vthe

VUnited VStates VAdopted VNames VCouncil.




DIF: Cognitive VLevel: VKnowledge REF: V p. V9
OBJ: V1NAT: VNCLEX VClient VNeeds VCategory: VSafe, VEffective
VCare VEnvironment VTOP: V Nursing VProcess VStep: V Assessment CON:
VPatient VEducation




2. Which Vsource Vcontains Vinformation Vspecific Vto Vnutritional Vsupplements?
a. USP VDictionary Vof VUSAN V &VInternational VDrug VNames
b. Natural VMedicines VComprehensive VDatabase
c. United VStates VPharmacopoeia/National VFormulary V(USP VNF)
d. Drug VInteraction VFacts
ANS: V C
United VStates VPharmacopoeia/National VFormulary Vcontains Vinformation Vspecific Vto
Vnutritional V supplements. VUSP VDictionary Vof VUSAN V & VInternational VDrug VNames V is Va

Vcompilation Vof Vdrug V names, Vpronunciation Vguide, Vand Vpossible V future VFDA Vapproved

Vdrugs; V it Vdoes V not Vinclude V nutritional V supplements. VNatural VMedicines VComprehensive

VDatabase Vcontains

evidence-based Vinformation Von Vherbal Vmedicines Vand Vherbal Vcombination Vproducts; Vit Vdoes
Vnot Vinclude V information Vspecific Vto Vnutritional V supplements. VDrug VInteraction VFacts

Vcontains Vcomprehensive V information Von Vdrug V interaction V facts; V it Vdoes V not Vinclude

Vnutritional Vsupplements.




DIF: Cognitive VLevel: VKnowledge REF: V p. V4 OBJ: V3
VNAT: V NCLEX VClient VNeeds VCategory: VPhysiological VIntegrity

TOP: V Nursing VProcess VStep: VAssessment CON: V Nutrition V|VPatient VEducation

3. Which Vdrug Vreference Vcontains Vdrug Vmonographs Vthat Vdescribe Vall Vdrugs Vin Va Vtherapeutic Vclass?
a. Drug VFacts Vand VComparisons

, 2

b. Drug VInteraction VFacts
c. Handbook Von VInjectable VDrugs
d. Martindale—The VComplete VDrug VReference
ANS: V A
Drug VFacts Vand VComparisons Vcontains Vdrug Vmonographs Vthat Vdescribe Vall Vdrugs
V in Va Vtherapeutic Vclass. VMonographs Vare Vformatted Vas Vtables Vto Vallow Vcomparison Vof

Vsimilar Vproducts, Vbrand V names, V manufacturers, Vcost Vindices, Vand V available Vdosage

V forms VOnline V version V is Vavailable.




DIF: Cognitive VLevel: VKnowledge REF: V p. V4 VTable V1.2
OBJ: V V 3 NAT: V NCLEX VClient VNeeds VCategory: VPhysiological VIntegrity
TOP: V Nursing VProcess VStep: VAssessment CON: V Safety V| VPatient VEducation V| VClinical VJudgment

4. Which Vdrug Vreference Vcontains Vmonographs Vabout VvirtuallyVeveryVsingle-entityVdrug
Vavailable Vin Vthe VUnited VStates Vand Vdescribes Vtherapeutic Vuses Vof Vdrugs, Vincluding
Vapproved Vand Vunapproved Vuses?

a. Martindale: VThe VComplete VDrug VReference
b. AHFS VDrug VInformation
c. Drug VReference
d. Drug VFacts Vand VComparisons
ANS: V B
AHFS VDrug VInformation Vcontains Vmonographs Vabout Vvirtually Vevery Vsingle-entity Vdrug
Vavailable Vin Vthe VUnited VStates Vand Vdescribes Vtherapeutic Vuses Vof Vdrugs, Vincluding Vapproved

Vand Vunapproved Vuses.




DIF: Cognitive VLevel: VKnowledge REF: V p. V4 VTable V1.2
OBJ: V V 3 NAT: V NCLEX VClient VNeeds VCategory:VPhysiological VIntegrity
TOP: V Nursing VProcess VStep: VPlanning CON: V Safety V| VPatient VEducation V| VClinical VJudgment

5. Which Vonline Vdrug Vreference Vmakes Vavailable Vto Vhealthcare Vproviders Vand Vthe Vpublic Va
Vstandard, Vcomprehensive, Vup-to-date Vlook Vup Vand Vdownloadable Vresource Vabout
Vmedicines?
a. American VDrug VIndex
b. American VHospital VFormulary
c. DailyMed
d. Drug VReference
ANS: V C
DailyMed Vmakes Vavailable Vto Vhealthcare Vproviders Vand Vthe Vpublic Va Vstandard,
Vcomprehensive, Vup-to-date Vlook Vup Vand Vdownloadable Vresource Vabout Vmedicines. VThe

VAmerican VDrug VIndex Vis V not Vappropriate V for Vpatient Vuse. VThe VAmerican VHospital

VFormulary V is V not Vappropriate V for Vpatient Vuse. VThe Vdrug Vreference V is V not Vappropriate V for

Vpatient Vuse.




DIF: Cognitive VLevel: VKnowledge REF: V p. V3 V| Vp. V4 OBJ: V3
VNAT: V NCLEX VClient VNeeds VCategory: VPhysiological VIntegrity

TOP: V NursingVProcess VStep: VImplementation
CON: V Safety V|VPatient VEducation V| VClinical VJudgment

6. Which Vlegislation Vauthorizes Vthe VFDA Vto Vdetermine Vthe VsafetyVof Va Vdrug Vbefore Vits Vmarketing?
a. Federal VFood, VDrug, Vand VCosmetic VAct V(1938)
b. Durham VHumphreyVAmendment V(1952)

, 3

c. Controlled VSubstances VAct V(1970)
d. Kefauver VHarris VDrug VAmendment V(1962)
ANS: V A
The VFederal VFood, VDrug, Vand VCosmetic VAct Vof V1938 Vauthorized Vthe VFDA Vto Vdetermine
Vthe Vsafety Vof Vall Vdrugs V before V marketing. VLater Vamendments Vand V acts Vhelped Vtighten

VFDA Vcontrol Vand Vensure Vdrug V safety. VThe VDurham VHumphrey V Amendment Vdefines Vthe

Vkinds Vof Vdrugs Vthat Vcannot Vbe Vused Vsafely Vwithout Vmedical Vsupervision V and Vrestricts Vtheir

Vsale Vto Vprescription V by Va V licensed Vpractitioner. VThe VControlled VSubstances VAct Vaddresses

Vonly Vcontrolled Vsubstances Vand Vtheir Vcategorization. VThe VKefauver VHarris VDrug

VAmendment Vensures Vdrug Vefficacy Vand Vgreater Vdrug Vsafety. VDrug V manufacturers Vare

Vrequired Vto Vprove Vto Vthe VFDA Vthe Veffectiveness V of Vtheir Vproducts Vbefore V marketing Vthem.




DIF: Cognitive VLevel: VKnowledge REF: V p. V5 VTable Vl.3
OBJ: V 5 NAT: VNCLEX VClient VNeeds VCategory: VPhysiological
VIntegrity VTOP: V Nursing VProcess VStep: V Assessment

CON: V Safety V| VPatient VEducation V| VEvidence V| VHealth VCare VLaw

7. Which Vclassification Vdoes Vmeperidine V(Demerol) Vfall Vunder?
a. I
b. II
c. III
d. IV
ANS: V B
Meperidine V(Demerol) Vis Va VSchedule VII Vdrug; Vit Vhas Va Vhigh Vpotential Vfor Vabuse Vand Vmay
Vlead Vto Vsevere Vpsychological Vand Vphysical Vdependence. VSchedule VI Vdrugs Vhave Vhigh

Vpotential Vfor Vabuse Vand V no Vrecognized V medical Vuse. VSchedule VIII Vdrugs Vhave V some

Vpotential V for Vabuse. VUse V may V lead Vto Vlow Vto Vmoderate Vphysical Vdependence Vor Vhigh

Vpsychological Vdependence. VSchedule VIV Vdrugs V have V low Vpotential V for Vabuse. VUse V may

V lead Vto V limited Vphysical Vor Vpsychological Vdependence.




DIF: Cognitive VLevel: VKnowledge REF: V p. V10 OBJ:
V2 VNAT: V NCLEX VClient VNeeds VCategory: VSafe, VEffective VCare

VEnvironment

TOP: V Nursing VProcess VStep: VAssessment CON: V Patient VEducation V| VAddiction V|VPain

8. Which Vaction Vwould Vthe VFDA Vtake Vto Vexpedite Vdrug Vdevelopment Vand Vapproval Vfor Van
Voutbreak Vof Vsmallpox?
a. List Vsmallpox Vas Va Vhealth Vorphan Vdisease.
b. Omit Vthe Vpreclinical Vresearch Vphase.
c. Extend Vthe Vclinical Vresearch Vphase.
d. Fast Vtrack Vthe Vinvestigational Vdrug.
ANS: V D
Once Vthe VInvestigational VNew VDrug VApplication Vhas Vbeen Vapproved, Vthe Vdrug Vcan Vreceive
Vhighest Vpriority Vwithin Vthe Vagency, Vwhich V is Vcalled V fast Vtracking. V A Vsmallpox Voutbreak

Vwould V become Va Vpriority Vconcern V in Vthe Vworld. V Orphan Vdiseases Vare V not Vresearched V in Va

Vpriority V manner. VPreclinical Vresearch V is V not Vomitted. VExtending Vany Vphase Vof Vthe Vresearch

Vwould V mean Va Vlonger Vtime Vto Vdevelop Va Vvaccine. VThe VFDA Vmust Vensure Vthat Vall Vphases Vof

Vthe Vpreclinical Vand Vclinical Vresearch Vphase V have V been Vcompleted V in Va Vsafe V manner.




DIF: Cognitive VLevel: VKnowledge REF: V V p. V7 OBJ: V 5

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Ascorers. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $16.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

67479 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 15 years now

Start selling
$16.49
  • (0)
Add to cart
Added